AMACAGEL
LIVE

Serial Number

98575628

Owner

AMACATHERA INC.

Attorney

Bradley M. Stohry

Filing Date

May 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AMACAGEL Trademark

Serial Number: 98575628

AMACAGEL is a trademark filed by AMACATHERA INC. on May 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

AMACATHERA INC.

611 University Avenue, Suite 1300
Toronto, ON M5G0B7 , CA

Entity Type: 03

Trademark Details

Filing Date

May 30, 2024

Registration Date

Not Registered

Goods & Services

Drug manufacturing services, namely, custom manufacture of pharmaceuticals by pharmaceutical compounders

Pharmaceutical drug development services; pharmaceutical research and development; Drug development services, namely, development of dermatological drugs

Hydrogel for medical purposes, namely, hydrogel used as a delivery vehicle for therapeutic agents, enzymes, antibodies, cells, anesthetics, analgesics, anti-inflammatories, antihistamines, antibiotics, respiratory and lung preparations, cardiovascular preparations, central nervous system drugs, oncolytics, anti-cancer preparations, lipid nanoparticles, metal salts, immunomodulators, immunosuppressives, immunogenic particles, vaccines, thyroid preparations, gene therapy preparations, peptides and peptide mimetics, hormones, steroids, vitamins, growth factors, and nucleic acid molecules; Hydrogel polymer matrix comprising hyaluronic acid and methyl cellulose for medical therapeutic purposes; Hydrogel for medical purposes, namely, injectable hydrogel for the prevention of fibrosis; Injectable local anesthetic, namely, injectable hydrogel comprising hyaluronic acid and methyl cellulose for medical purposes; human vaccine preparations; pharmaceutical preparations for use in gene therapy; veterinary vaccines

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 19, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 19, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 19, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2025 CRFA
ASSIGNED TO LIE
Dec 18, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 10, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 24, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 24, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 24, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 19, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 17, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 17, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 17, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 16, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2024 NWOS
NEW APPLICATION ENTERED
May 30, 2024 NWAP